What is Oppenheimer's price target for ATRC?

Oppenheimer's latest stated price target for AtriCure Inc. (ATRC) is $32, from its action on Apr 23, 2024.

What is Oppenheimer's rating on ATRC?

Oppenheimer rates ATRC Perform, a neutral rating, as of Feb 18, 2026.

When did Oppenheimer last change its view on ATRC?

On Feb 18, 2026, Oppenheimer downgrades to Perform from Outperform.

Oppenheimer ATRC price target and rating history

Oppenheimer rates AtriCure Inc. (ATRC) Perform with a $32 price target, as of its latest action on Feb 18, 2026. It has published 3 rating actions on ATRC since August 2021, including 1 upgrade and 2 downgrades.

Current rating: Perform
Price target: $32
Median target, all firms: Too few
Actions on ATRC: 3

Every Oppenheimer rating on ATRC

Feb 18, 2026
DowngradeOppenheimer downgrades to Perform from Outperform
Apr 23, 2024
UpgradeOppenheimer upgrades to Outperform from Perform, price target $32
Aug 5, 2021
DowngradeOppenheimer downgrades to Perform from Outperform

Questions about Oppenheimer and ATRC

What is Oppenheimer's price target for ATRC?: Oppenheimer's latest stated price target for AtriCure Inc. (ATRC) is $32, from its action on Apr 23, 2024.
What is Oppenheimer's rating on ATRC?: Oppenheimer rates ATRC Perform, a neutral rating, as of Feb 18, 2026.
When did Oppenheimer last change its view on ATRC?: On Feb 18, 2026, Oppenheimer downgrades to Perform from Outperform.

More ATRC rating histories

Needham3

All Oppenheimer ratings ATRC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.